ECMOHO Announces Strategic Cooperation Agreement with South Korean Group ChongKunDang to Establish Premium Health Food Distribution

SHANGHAI, China, July 16, 2021 (GLOBE NEWSWIRE) – ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading provider of integrated solutions to the healthcare and wellness market being in China, today is pleased to announce a strategic cooperation agreement with well-known South Korean pharmaceutical company, ChongKunDang Group (hereinafter referred to as “CKD”), providing global marketing and multi-channel sales for One-stop retail solutions for health products from CKD in China. With state-of-the-art equipment and state-of-the-art technology as a foundation, CKD will be able to provide Chinese consumers with diverse and high-quality health products, including probiotics, through ECMOHO’s established and extensive domestic distribution channels.

ECMOHO, as the leading online healthcare retailing service provider in China, has cooperated with well-known domestic and foreign healthcare brands such as Harbin Pharmaceutical, ONLLY, Jiangzhong Pharmaceutical, Bayer and Puritan’s Pride , among others. Given ECMOHO’s extensive experience in collecting and analyzing customer data, researching new product trends, as well as digital marketing and promotion in the national health food market, the new partnership will provide CKD in-depth analysis of various user groups, including Chinese Gen Z. Since the start of 2021, ECMOHO has expanded to new social media platforms, such as TikTok and Kuaishou, and has involved key opinion leader (KOL) and key opinion consumer (KOC) resources to promote and distribute professional content and enable its business partners to achieve more efficient and faster growth in the Chinese market.

CKD was founded in 1941 and is one of South Korea’s oldest pharmaceutical companies, with nearly a century of history. Its LACTO-FIT brand of probiotics has maintained a leading position in the South Korean probiotic market since its inception and has won the Korean National Functional Health Food Award for 3 consecutive years. Upon its debut in the Chinese market in May 2020, LACTO-FIT won praise from Chinese consumers and saw sales soar to RMB 100 million, creating a premium health product offering that meets consumer demands. for effective and high quality healthy foods.

Ms. Zoe Wang, CEO of ECMOHO, said, “With the boom in China’s health food industry, ECMOHO provides invaluable sales and marketing services to many CKD brands through channels such as Tmall, JD, Koala, TikTok, and Kuaishou, which cover many categories of nutrition and health care products. The partnership will be mutually beneficial as ECMOHO and CKD work together to bring high quality health products to Chinese consumers. “

“As the standard of living increases, Chinese consumers demand better health products, resulting in the growth and expansion of many health industries. Among them, probiotics have been relatively popular in recent years, which involves daily supplements, diet foods, medications, and even pet products, ”Ms. Zoe Wang continued.

Mr. Li Xin, Chief Financial Officer of ECMOHO, added, “Due to an accelerated pace of work and life and increased physical and mental pressures, consumers have turned to probiotics to improve health. immunity and digestion, especially to help absorption of nutrients and reduce intestinal inflammation. Probiotics also help fight indigestion and congenital lactase deficiency, and have other obvious health benefits. Data shows that the probiotics market in China is growing by 10-15% per year; in 2015, it was 48.6 billion RMB, in 2020 it reached 84.9 billion RMB. However, the demand for probiotics has become more and more personalized and the market lacks sufficient high-end products with improved efficacy and quality that fully meet the needs of many consumers.

ECMOHO’s cooperation with CKD was chosen after careful consideration and analysis of the health food industry, and after proposing a new development strategy. As the demand for low and mid-range health foods level off, the introduction of high-quality products will drive consumer demand. Meanwhile, ECMOHO will also develop customized probiotic products to meet the needs of different groups of consumers with various health concerns.

ECMOHO’s extensive and large-scale national marketing network, built over 10 years, will help ensure that CKD’s high-end probiotic products can quickly reach Chinese consumers in all cities and regions, including those in national cities. low-level, as well as attracting young consumers through new tastes and diversified product offerings. The roughly 11 million paying users of ECMOHO are expected to help drive demand for CKD’s high-quality probiotic products. CKD, through continuous research and development technology in the field of probiotics, will ensure continuous improvement in the efficacy and quality of its products, creating significant advantages in the Chinese high-end health food market.

About ECMOHO Ltd.

ECMOHO is one of the leading providers of integrated solutions in the health and wellness market in China. The company organizes and sells the world’s best brands and quality products to health-conscious Chinese consumers. Our technology, network, and marketing and distribution expertise allow us to connect families with advanced health supplements, nutritional and food products, personal care products, household health care equipment and other health products. well-being. In more than ten years of activity, ECMOHO has established an ecosystem of products and trusted relationships to provide personalized solutions that promote health regeneration, confer therapeutic benefits and increase the longevity of our dedicated consumers to maintain health. For more information, please visit

For investor and media inquiries, please contact:
Investor Relations
E-mail: [email protected]

Forward-looking statements
This press release contains statements which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. These statements include statements regarding the current intention, belief or expectations of the Company and its officers and the assumptions upon which such statements are based. When the Company uses words such as “may”, “will”, “intend”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate” or similar phrases that do not relate solely to historical matters, it makes forward-looking statements. Potential investors are cautioned that these forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by these forward-looking statements. For these and other reasons, investors are cautioned not to place undue reliance on any forward-looking statements contained in this press release. The Company assumes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unforeseen events or changes in future operating results.

Contact of the investor relations agency:

William Tu / Scott Powell
Skyline Corporate Communications Group, LLC
One Rockefeller Plaza, 11th Floor
New York, New York 10020
Office: (646) 893-5835
E-mail: [email protected]

Source link

About Emilie Brandow


Check Also

(Korea Herald EDITORIAL September 23)

Undue sufferingRelieving the hardships of young adults does not require sympathetic rhetoric, but a change …

Leave a Reply

Your email address will not be published. Required fields are marked *